Terms: = Uterine cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Treatment
13 results:
1. Establishment and validation of preclinical models of smarca4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
Wong NKY; Llaurado Fernandez M; Kommoss FKF; Praveen Kumar P; Kim H; Liu J; Zhang G; Coatham M; Lin YY; Haegert AM; Volik S; Le Bihan S; Collins CC; Fu Y; Postovit LM; von Deimling A; Wu R; Xue H; Wang Y; Köbel M; Carey MS; Lee CH
Gynecol Oncol; 2023 Sep; 176():162-172. PubMed ID: 37556934
[TBL] [Abstract] [Full Text] [Related]
2. Pathological characteristics and immune microenvironment of smarca4-deficient undifferentiated uterine sarcoma.
Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
[TBL] [Abstract] [Full Text] [Related]
3. smarca4-Deficient Carcinoma of uterine Cervix Resembling SCCOHT-Case Report.
Sirák I; Laco J; Vošmiková H; Mell LK; Herrera FG; Šenkeříková M; Vošmik M
Pathol Oncol Res; 2021; 27():1610003. PubMed ID: 34970085
[TBL] [Abstract] [Full Text] [Related]
4. Clinico-pathological features associated with mismatch repair deficiency in endometrial undifferentiated/dedifferentiated carcinoma: A systematic review and meta-analysis.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Riccardi C; Mollo A; Zullo F; Insabato L
Gynecol Oncol; 2021 Feb; 160(2):579-585. PubMed ID: 33276986
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas.
Zhang K; Liu Y; Liu X; Du J; Wang Y; Yang J; Li Y; Liu C
Pathology; 2021 Feb; 53(2):179-186. PubMed ID: 33070954
[TBL] [Abstract] [Full Text] [Related]
6. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy.
Libertini M; Hallin M; Thway K; Noujaim J; Benson C; van der Graaf W; Jones RL
Int J Surg Pathol; 2021 Feb; 29(1):4-20. PubMed ID: 32909482
[TBL] [Abstract] [Full Text] [Related]
7. Small Cell Carcinoma of the Ovary: Clinicopathologic and Immunohistochemical Analysis of 7 New Cases of a Rare Malignancy.
Gupta P; Kapatia G; Gupta N; Dey P; Rohilla M; Gupta A; Rai B; Suri V; Rajwanshi A; Srinivasan R
Int J Surg Pathol; 2021 May; 29(3):236-245. PubMed ID: 32772748
[TBL] [Abstract] [Full Text] [Related]
8. Germline mutations of smarca4 in small cell carcinoma of the ovary, hypercalcemic type and in smarca4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.
Connor YD; Miao D; Lin DI; Hayne C; Howitt BE; Dalrymple JL; DeLeonardis KR; Hacker MR; Esselen KM; Shea M
Gynecol Oncol; 2020 Apr; 157(1):106-114. PubMed ID: 31954538
[TBL] [Abstract] [Full Text] [Related]
9. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
10. Undifferentiated Endometrial Carcinoma, an Immunohistochemical Study Including PD-L1 Testing of a Series of Cases From a Single cancer Center.
Al-Hussaini M; Lataifeh I; Jaradat I; Abdeen G; Otay L; Badran O; Abu Sheikha A; Dayyat A; El Khaldi M; Ashi Al-Loh S
Int J Gynecol Pathol; 2018 Nov; 37(6):564-574. PubMed ID: 30059455
[TBL] [Abstract] [Full Text] [Related]
11. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
12. Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.
Mirkovic J; Sholl LM; Garcia E; Lindeman N; MacConaill L; Hirsch M; Dal Cin P; Gorman M; Barletta JA; Nucci MR; McCluggage WG; Howitt BE
Mod Pathol; 2015 Nov; 28(11):1504-14. PubMed ID: 26336887
[TBL] [Abstract] [Full Text] [Related]
13. Maintenance of integrated proviral gene expression requires Brm, a catalytic subunit of SWI/SNF complex.
Mizutani T; Ito T; Nishina M; Yamamichi N; Watanabe A; Iba H
J Biol Chem; 2002 May; 277(18):15859-64. PubMed ID: 11850427
[TBL] [Abstract] [Full Text] [Related]
